| Literature DB >> 35299624 |
Matthew Muir1, Rajan Patel2, Jeffrey Traylor3, Dhiego Chaves de Almeida Bastos4, Sarah Prinsloo1, Ho-Ling Liu5, Kyle Noll6, Jeffrey Wefel6, Sudhakar Tummala7, Vinodh Kumar8, Sujit Prabhu1.
Abstract
Many studies have established a link between extent of resection and survival in patients with gliomas. Surgeons must optimize the oncofunctional balance by maximizing the extent of resection and minimizing postoperative neurological morbidity. Preoperative functional imaging modalities are important tools for optimizing the oncofunctional balance. Transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (fMRI) are non-invasive imaging modalities that can be used for preoperative functional language mapping. Scarce data exist evaluating the accuracy of these preoperative modalities for language mapping compared with gold standard intraoperative data in the same cohort. This study compares the accuracy of fMRI and TMS for language mapping compared with intraoperative direct cortical stimulation (DCS). We also identified significant predictors of preoperative functional imaging accuracy, as well as significant predictors of functional outcomes. Evidence from this study could inform clinical judgment as well as provide neuroscientific insight. We used geometric distances to determine copositivity between preoperative data and intraoperative data. Twenty-eight patients were included who underwent both preoperative fMRI and TMS procedures, as well as an awake craniotomy and intraoperative language mapping. We found that TMS shows significantly superior correlation to intraoperative DCS compared with fMRI. TMS also showed significantly higher sensitivity and negative predictive value than specificity and positive predictive value. Poor cognitive baseline was associated with decreased TMS accuracy as well as increased risk for worsened aphasia postoperatively. TMS has emerged as a promising preoperative language mapping tool. Future work should be done to identify the proper role of each imaging modality in a comprehensive, multimodal approach to optimize the oncofunctional balance.Entities:
Keywords: aphasia; brain mapping; direct cortical stimulation; eloquent; functional MRI; gliomas; transcranial magnetic stimulation
Year: 2022 PMID: 35299624 PMCID: PMC8923233 DOI: 10.3389/fnins.2022.833073
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
FIGURE 13D reconstruction of a preoperative plan depicting the transcranial magnetic stimulation (TMS) positive points (red) and blood oxygen level–dependent (BOLD) signal (orange) in context of the tumor (blue).
FIGURE 2Scheme illustrating the comparison between the direct cortical stimulation (DCS) points (green) and the transcranial magnetic stimulation (TMS) positive points (yellow) and TMS negative points (red) using the distance equation in context of the craniotomy (blue).
FIGURE 3Scheme illustrating the comparison between the direct cortical stimulation (DCS) points (red) and the blood oxygen level–dependent (BOLD) signal (yellow) in context of the craniotomy (blue).
Confusion matrices for transcranial magnetic stimulation (TMS) versus direct cortical stimulation (DCS) (left) and functional magnetic resonance imaging (fMRI) versus DCS (right).
| DCS+ | DCS– | DCS+ | DCS– | ||
| TMS+ | 27 | 146 | fMRI+ | 5 | 12 |
| TMS– | 4 | 302 | fMRI− | 2 | 8 |
| The sensitivity of TMS for language mapping was 87%, specificity was 67%, positive predictive value was 16%, and negative predictive value was 99%. | The sensitivity of fMRI for language mapping was 71%, specificity was 40%, positive predictive value was 29%, and negative predictive value was 80%. | ||||
Patient characteristics.
| Patient | Age (y) | Gender | Tumor histology | Location | Handedness | Preoperative aphasia | Postoperative aphasia? | Postoperative aphasia compared with preoperative | Postoperative aphasia at 1 month | 1 month compared with preoperative |
| 1 | 57 | Female | Glioblastoma | Left temporal | Right | Yes | Yes | Aggravated | Yes | Aggravated |
| 2 | 46 | Female | Anaplastic astrocytoma | Left frontal | Right | No | Yes | Aggravated | Yes | Aggravated |
| 3 | 45 | Male | Diffuse glioma | Left temporal | Right | Yes | Yes | Aggravated | Yes | Aggravated |
| 4 | 57 | Male | Glioblastoma | Left temporoparietal | Right | Yes | Yes | Aggravated | Yes | Aggravated |
| 5 | 28 | Male | Anaplastic astrocytoma | Left temporal | Mixed | No | Yes | Aggravated | Yes | Aggravated |
| 6 | 63 | Female | Anaplastic oligodendroglioma | Left frontal | Right | No | Yes | Aggravated | Yes | Aggravated |
| 7 | 60 | Male | Glioblastoma | Left frontal | Right | No | Yes | Aggravated | Yes | Aggravated |
| 8 | 69 | Female | Anaplastic astrocytoma | Left frontal | Right | No | Yes | Aggravated | Yes | Aggravated |
| 9 | 63 | Female | Glioblastoma | Left temporal | Right | Yes | Yes | Aggravated | Yes | Aggravated |
| 10 | 34 | Male | Anaplastic astrocytoma | Left temporal | Right | Yes | Yes | Unchanged | Yes | Unchanged |
| 11 | 58 | Male | Glioblastoma | Left temporal | Right | Yes | Yes | Unchanged | No follow-up | N/A |
| 12 | 35 | Male | Anaplastic astrocytoma | Left temporal | Right | No | No | Unchanged | No | Unchanged |
| 13 | 66 | Female | Anaplastic oligodendroglioma | Left insular/temporal | Mixed | Yes | Yes | Aggravated | Yes | Unchanged |
| 14 | 60 | Male | Anaplastic astrocytoma | Left frontal | Right | No | Yes | Aggravated | No | Unchanged |
| 15 | 56 | Male | Glioblastoma | Left temporal | Right | No | Yes | Aggravated | No | Unchanged |
| 16 | 43 | Male | Diffuse astrocytoma | Left temporal | Right | No | No | Unchanged | No | Unchanged |
| 17 | 22 | Female | Glioblastoma | Left temporal | Right | No | Yes | Aggravated | No | Unchanged |
| 18 | 31 | Male | Diffuse astrocytoma | Left frontal | Right | No | No | Unchanged | No | Unchanged |
| 19 | 70 | Male | Glioblastoma | Left temporal | Right | Yes | Yes | Unchanged | No follow-up | N/A |
| 20 | 71 | Male | Glioblastoma | Left temporal | Right | No | Yes | Aggravated | No | Unchanged |
| 21 | 23 | Female | Diffuse astrocytoma | Left frontal | Right | No | No | Unchanged | No | Unchanged |
| 22 | 61 | Male | Glioblastoma | Left temporal | Right | No | Yes | Aggravated | Yes | Unchanged |
| 23 | 27 | Female | Diffuse astrocytoma | Left parietal | Right | No | No | Unchanged | No | Unchanged |
| 24 | 67 | Female | Glioblastoma | Left frontal | Right | No | No | Unchanged | No | Unchanged |
| 25 | 71 | Female | Glioblastoma | Left frontal | Right | No | No | Unchanged | No | Unchanged |
| 26 | 40 | Male | Anaplastic oligodendroglioma | Left frontal | Right | No | Yes | Aggravated | No follow-up | N/A |
| 27 | 58 | Female | Glioblastoma | Left temporal | Right | No | Yes | Aggravated | No follow-up | N/A |
| 28 | 64 | Female | Glioblastoma | Left frontal | Right | No | No | Unchanged | No | Unchanged |
Univariate statistical analysis performed for each preoperative modality in relation to predicting intraoperative direct cortical stimulation (DCS) points.
| Odds ratio | 95% Confidence interval | ||
| TMS | 15.1 | 5.2–43.8 | <0.0001 |
| fMRI | 1.7 | 0.26–10.8 | 0.59 |
TMS, transcranial magnetic stimulation; fMRI, functional magnetic resonance imaging.
Preoperative variables used to perform univariate analysis of transcranial magnetic stimulation (TMS) performance along with false positives (FP), true positives (TP), true negatives (TN), and false negatives (FN) for each patient.
| Patient | Age | Tumor grade | Tumor location | Boston naming test ( | Semantic fluency ( | Token test ( | MAE_COWA_Z ( | TP | FP | TN | FN |
| 1 | 60 | 3 | Posterior | −0.9 | −1.6 | 0.4 | −1.18 | 0 | 16 | 44 | 0 |
| 2 | 61 | 4 | Anterior | −1.1 | −0.8 | −1.3 | −2.13 | 0 | 10 | 18 | 0 |
| 3 | 57 | 4 | Anterior | −3.3 | −2 | 0.4 | −3.12 | 0 | 4 | 46 | 0 |
| 4 | 63 | 4 | Posterior | −1.4 | −3.7 | −0.7 | −1.14 | 0 | 13 | 10 | 0 |
| 5 | 71 | 4 | Anterior | −3 | −3.7 | 0.9 | −1.86 | 0 | 12 | 4 | 0 |
| 6 | 60 | 4 | Anterior | −2.4 | −1.4 | −2.8 | 0 | 3 | 9 | 0 | |
| 7 | 27 | 4 | Anterior | −1.7 | −2.7 | 0.9 | −0.31 | 0 | 12 | 3 | 0 |
| 8 | 63 | 2 | Anterior | −0.6 | −3.2 | −0.4 | −2.22 | 7 | 6 | 0 | 0 |
| 9 | 56 | 3 | Posterior | −3 | −3.8 | 0.9 | −1.93 | 0 | 8 | 19 | 0 |
| 10 | 22 | 4 | Anterior | −3.3 | −1.6 | 0.9 | −0.73 | 1 | 3 | 8 | 0 |
| 11 | 46 | 4 | Posterior | −3.3 | −3.9 | −1.3 | −1.45 | 0 | 3 | 2 | 0 |
| 12 | 70 | 3 | Posterior | −0.8 | −0.9 | −2 | −2.5 | 3 | 5 | 4 | 2 |
| 13 | 31 | 4 | Anterior | −0.7 | −0.4 | 0.9 | −0.86 | 0 | 3 | 15 | 0 |
| 14 | 23 | 2 | Anterior | 0.8 | −0.2 | 0.9 | −0.76 | 3 | 2 | 8 | 0 |
| 15 | 69 | 2 | Posterior | −0.8 | −2 | −2.6 | −3.53 | 0 | 4 | 7 | 0 |
| 16 | 35 | 3 | Posterior | −2.9 | −1.6 | 0.9 | 1.01 | 3 | 3 | 5 | 1 |
| 17 | 43 | 2 | Anterior | −1.6 | −1.1 | −1.3 | −1.72 | 0 | 3 | 0 | 0 |
| 18 | 58 | 4 | Anterior | −0.7 | 0.1 | −0.1 | −1.38 | 0 | 0 | 11 | 0 |
| 19 | 57 | 4 | Posterior | 1.5 | −1.8 | −0.1 | −0.82 | 1 | 4 | 13 | 0 |
| 20 | 66 | 3 | Anterior | −2.5 | −3.1 | 0.9 | −1.72 | 0 | 4 | 3 | 0 |
| 21 | 45 | 2 | Anterior | −0.2 | −0.9 | −1.3 | −1.29 | 0 | 5 | 15 | 0 |
| 22 | 28 | 3 | Posterior | N/A | −2.1 | 0.9 | −1.4 | 5 | 5 | 3 | 0 |
| 23 | 58 | 4 | Posterior | −1.7 | 0.2 | −2.6 | −1.4 | 1 | 2 | 11 | 1 |
| 24 | 64 | 4 | Anterior | −0.6 | −0.4 | 0.4 | −1.52 | 0 | 3 | 15 | 0 |
| 25 | 67 | 4 | Anterior | −1.4 | −0.1 | 0.4 | −1.66 | 1 | 6 | 12 | 0 |
| 26 | 40 | 3 | Anterior | −2 | −1.4 | 0.9 | −1.72 | 2 | 3 | 1 | 0 |
| 27 | 71 | 4 | Posterior | −0.9 | −1.1 | −2.6 | −2.93 | 0 | 0 | 10 | 0 |
| 28 | 34 | 3 | Anterior | 1.5 | −2.2 | 0.4 | −2.54 | 0 | 4 | 6 | 0 |